Particulars (Rs Crores) | Q3FY24 | Q3FY23 | YoY (%) | Q2FY24 | QoQ (%) |
---|---|---|---|---|---|
Revenue | 138.50 | 109.20 | 27.00% | 145.26 | -5.00% |
EBITDA | 40.40 | 28.50 | 42.00% | 36.87 | 10.00% |
EBITDA Margin (%) | 29.00% | 26.00% | 12.00% | 25.00% | 15.00% |
PAT | 33.00 | 22.40 | 47.00% | 30.00 | 10.00% |
Source: Company Filings; StockAxis Research
Q3FY24 Result highlights
Fineotex Chemical Ltd (FCL) exhibited impressive earnings growth for the quarter
ended Q3FY24. Consolidated net sales rose 27% YoY to Rs.138.5 cr as compared to
Rs.109.2 cr registered in the same quarter of the corresponding fiscal driven by
sales growth in volumes across segments and strong demand from the customers. Gross
Profit jumped 28% YoY to Rs.57.4 cr led by higher revenues. On the operating Profit,
consolidated EBITDA witnessed a robust growth of 41.3% YoY to Rs.40 cr aided by
higher gross profit. EBITDA Margins expanded by 300 bps to 29.1% YoY driven by lower
raw material costs. FCL has passed on some of the benefits of lower raw material
prices to customers, resulting in declining realizations, although COGS has improved.
PAT jumped 47% YoY to Rs.33 cr. The growth in PAT was fuelled by steady sales growth
in volumes across segments and robust operational performance.
Key Conference call takeaways
Fineotex Chemicals delivered healthy earnings growth in Q3FY24 driven by an increase in sales volume. With the decline in cotton prices, we anticipate an improved performance from the company in the upcoming quarters. It seems that the situation is becoming more stable with respect to issues like the Red Sea crisis, war, and macro events. Furthermore, the company's recent fundraising efforts for foreign opportunities could provide an extra boost to its growth prospects.
Considering the company has established a strong position in specialty textile chemicals, a reputed clientele base, a promising growth outlook for Textile Chemical Industry and Cleaning and Hygiene, a healthy balance sheet, superior return ratios, consistent financial performance, diversified product portfolio, recent collaborations to expand geographical presence, strong technical expertise, inorganic growth opportunities, realisation of synergies with Biotex, strong capacity utilisation, FCL is poised to sustain earnings growth momentum in the coming quarters.
At CMP of Rs.424, the stock is trading at 30x FY25e which appears reasonable and hence, we maintain a Hold rating on the stock.
Particulars (Rs Crores) | Q3FY24 | Q3FY23 | YoY (%) | Q2FY24 | QoQ (%) |
---|---|---|---|---|---|
Revenue | 138.50 | 109.20 | 27.00% | 145.26 | -5.00% |
COGS | 81.00 | 64.20 | 26.00% | 90.45 | -10.00% |
Gross Profit | 57.50 | 45.00 | 28.00% | 54.81 | 5.00% |
Gross Profit Margin (%) | 42.00% | 41.00% | 1.00% | 38.00% | 10.00% |
Employee Benefit Expense | 5.50 | 4.60 | 20.00% | 5.04 | 9.00% |
Other Expense | 11.60 | 11.90 | -3.00% | 12.90 | -10.00% |
EBITDA | 40.40 | 28.50 | 42.00% | 36.87 | 10.00% |
EBITDA Margin (%) | 29.00% | 26.00% | 12.00% | 25.00% | 15.00% |
Depreciation and Amortisation | 1.40 | 1.10 | 27.00% | 1.40 | 0.00% |
EBIT | 39.00 | 27.40 | 42.00% | 35.47 | 10.00% |
EBIT Margin (%) | 28.00% | 25.00% | 12.00% | 24.00% | 15.00% |
Finance Cost | 0.30 | 0.20 | 50.00% | 0.26 | 15.00% |
Other Income | 4.90 | 1.80 | 172.00% | 3.81 | 29.00% |
PBT | 43.60 | 29.00 | 50.00% | 39.02 | 12.00% |
Tax | 10.60 | 6.60 | 61.00% | 9.34 | 13.00% |
PAT | 33.00 | 22.40 | 47.00% | 30.00 | 10.00% |
PAT Margin (%) | 24.00% | 21.00% | 16.00% | 21.00% | 15.00% |
EPS (Rs) | 2.95 | 2.00 | 48.00% | 2.83 | 4.00% |
Source: Company Filings; StockAxis Research